Technical Data
Cytomegalovirus Glycoprotein B, Late Neutralizing Antigen (CMV gB, CMV Glycoprotein GP55, HCMV, Human Herpes virus 5, HHV-5, HHV5, UL55)
Glycoprotein B (gB) is the main antigenic protein within the envelope of HCMV. It is required for CMV mediated membrane fusion along with the gH/gL complex. The unprocessed precursor of HCMV gB is 906aa in length, with a MW of ~100kD.

Suitable for use in ELISA and Immunofluorescence. Other applications not tested.

Recommended Dilutions:
Immunofluorescence: Use acetone-fixed CMV infected cells or frozen sections.
Optimal dilutions to be determined by the researcher.

Recommended Secondary Antibodies:
I1904-06C: IgG, H&L (HRP) (X-Adsorbed) Pab Gt xMo
I1904-06H: IgG, H&L (HRP) (X-Adsorbed) Pab Gt xMo

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
MabIgG2a10B2664Affinity Purified
200ug-20CBlue IceMouse
Human CMV extracts.
Purified by Protein A affinity chromatography.
Supplied as a liquid in PBS, 0.09% sodium azide.
Recognizes Cytomegalovirus Glycoprotein B, Late Neutralizing Antigen. Reacts with MRC-5 infected cells but not uninfected cells. This antibody has been found to be neutralizing.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.